183 related articles for article (PubMed ID: 24001087)
1. Stiripentol in refractory status epilepticus.
Grosenbaugh DK; Mott DD
Epilepsia; 2013 Sep; 54 Suppl 6():103-5. PubMed ID: 24001087
[TBL] [Abstract][Full Text] [Related]
2. Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus.
Grosenbaugh DK; Mott DD
Neuropharmacology; 2013 Apr; 67():136-43. PubMed ID: 23168114
[TBL] [Abstract][Full Text] [Related]
3. The impact of diazepam's discovery on the treatment and understanding of status epilepticus.
Goodkin HP; Kapur J
Epilepsia; 2009 Sep; 50(9):2011-8. PubMed ID: 19674049
[TBL] [Abstract][Full Text] [Related]
4. Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain.
Auvin S; Lecointe C; Dupuis N; Desnous B; Lebon S; Gressens P; Dournaud P
Epilepsia; 2013 Dec; 54(12):2082-90. PubMed ID: 24117113
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.
Joshi S; Rajasekaran K; Hawk KM; Brar J; Ross BM; Tran CA; Chester SJ; Goodkin HP
Epilepsia; 2015 Sep; 56(9):1355-65. PubMed ID: 26248944
[TBL] [Abstract][Full Text] [Related]
6. Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus.
Feng HJ; Mathews GC; Kao C; Macdonald RL
J Neurophysiol; 2008 Mar; 99(3):1285-93. PubMed ID: 18216225
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy.
Leroy C; Poisbeau P; Keller AF; Nehlig A
J Physiol; 2004 Jun; 557(Pt 2):473-87. PubMed ID: 15034126
[TBL] [Abstract][Full Text] [Related]
8. Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
Quilichini PP; Chiron C; Ben-Ari Y; Gozlan H
Epilepsia; 2006 Apr; 47(4):704-16. PubMed ID: 16650136
[TBL] [Abstract][Full Text] [Related]
9. Stiripentol for the treatment of super-refractory status epilepticus.
Strzelczyk A; Kortland LM; Knake S; Rosenow F
Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
[TBL] [Abstract][Full Text] [Related]
10. GABA(A) receptor internalization during seizures.
Goodkin HP; Sun C; Yeh JL; Mangan PS; Kapur J
Epilepsia; 2007; 48 Suppl 5():109-13. PubMed ID: 17910589
[TBL] [Abstract][Full Text] [Related]
11. Early polytherapy for benzodiazepine-refractory status epilepticus.
Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
[TBL] [Abstract][Full Text] [Related]
12. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.
Naylor DE; Liu H; Wasterlain CG
J Neurosci; 2005 Aug; 25(34):7724-33. PubMed ID: 16120773
[TBL] [Abstract][Full Text] [Related]
13. Status epilepticus: Role for etiology in determining response to benzodiazepines.
Joshi S; Rajasekaran K; Hawk KM; Chester SJ; Goodkin HP
Ann Neurol; 2018 Apr; 83(4):830-841. PubMed ID: 29572918
[TBL] [Abstract][Full Text] [Related]
14. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication.
Althaus AL; McCarren HS; Alqazzaz A; Jackson C; McDonough JH; Smith CD; Hoffman E; Hammond RS; Robichaud AJ; Doherty JJ
Epilepsy Behav; 2017 Mar; 68():22-30. PubMed ID: 28109985
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
16. Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus.
Barmashenko G; Hefft S; Aertsen A; Kirschstein T; Köhling R
Epilepsia; 2011 Sep; 52(9):1570-8. PubMed ID: 21899534
[TBL] [Abstract][Full Text] [Related]
17. Bumetanide is not capable of terminating status epilepticus but enhances phenobarbital efficacy in different rat models.
Töllner K; Brandt C; Erker T; Löscher W
Eur J Pharmacol; 2015 Jan; 746():78-88. PubMed ID: 25445051
[TBL] [Abstract][Full Text] [Related]
18. Acute cellular alterations in the hippocampus after status epilepticus.
Macdonald RL; Kapur J
Epilepsia; 1999; 40 Suppl 1():S9-20; discussion S21-2. PubMed ID: 10421557
[TBL] [Abstract][Full Text] [Related]
19. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
[TBL] [Abstract][Full Text] [Related]
20. Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence.
Liang J; Cagetti E; Olsen RW; Spigelman I
J Pharmacol Exp Ther; 2004 Sep; 310(3):1234-45. PubMed ID: 15126642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
